Syros Pharmaceuticals Inc (SYRS)
0.91
-0.05 (-5.47%)
USD |
NASDAQ |
Jul 01, 16:00
0.9181
+0.01 (+0.89%)
After-Hours: 20:00
Syros Pharmaceuticals Shareholders Equity (Quarterly): 62.74M for March 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 62.74M |
| December 31, 2021 | 85.22M |
| September 30, 2021 | 106.06M |
| June 30, 2021 | 129.98M |
| March 31, 2021 | 149.88M |
| December 31, 2020 | 90.55M |
| September 30, 2020 | 45.94M |
| June 30, 2020 | 62.41M |
| March 31, 2020 | 76.54M |
| December 31, 2019 | 79.18M |
| September 30, 2019 | 94.57M |
| June 30, 2019 | 111.92M |
| March 31, 2019 | 64.02M |
| Date | Value |
|---|---|
| December 31, 2018 | 78.59M |
| September 30, 2018 | 94.84M |
| June 30, 2018 | 108.71M |
| March 31, 2018 | 104.50M |
| December 31, 2017 | 65.32M |
| September 30, 2017 | 78.59M |
| June 30, 2017 | 91.08M |
| March 31, 2017 | 70.14M |
| December 31, 2016 | 80.60M |
| September 30, 2016 | 90.78M |
| June 30, 2016 | 53.39M |
| March 31, 2016 | 63.92M |
| December 31, 2015 | 34.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
45.94M
Minimum
Sep 2020
149.88M
Maximum
Mar 2021
88.92M
Average
85.22M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Synthetic Biologics Inc | 68.03M |
| Celsion Corp | 46.27M |
| Alaunos Therapeutics Inc | 49.12M |
| Chimerix Inc | 47.80M |
| Viking Therapeutics Inc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.08M |
| Total Liabilities (Quarterly) | 89.34M |
| Debt to Equity Ratio | 0.6446 |
| Current Ratio | 4.221 |
| Net Debt Paydown Yield | -0.24% |